Improving access to rare disease treatments : subsidy, pricing, and payment schemes
Year of publication: |
2023
|
---|---|
Authors: | Olsder, Wendy ; Martagan, Tugce ; Tang, Christopher S. |
Published in: |
Management science : journal of the Institute for Operations Research and the Management Sciences. - Hanover, Md. : INFORMS, ISSN 1526-5501, ZDB-ID 2023019-9. - Vol. 69.2023, 9, p. 5256-5274
|
Subject: | exogenous pricing scheme | government subsidy schemes | orphan drugs | outcome-based payment | patient welfare | rare diseases | Subvention | Subsidy | Arzneimittel | Pharmaceuticals | Gesundheitskosten | Health care costs | Krankheit | Disease | Theorie | Theory | Wirkungsanalyse | Impact assessment | Agrarsubvention | Agricultural subsidy |
-
Converting a drug from off-label to on-label use : government subsidies and patient welfare
Olsder, Wendy, (2023)
-
Hausken, Kjell, (2021)
-
Financial analysis of the access to pharmacotherapy for rare diseases in Bulgaria
Zlatareva, Albena, (2014)
- More ...
-
Improving Access to Rare Disease Treatments : Subsidy, Pricing, and Payment Schemes
Olsder, Wendy, (2020)
-
Converting a drug from off-label to on-label use : government subsidies and patient welfare
Olsder, Wendy, (2023)
-
The impact of uncertainty on a production line
Tang, Christopher S., (1990)
- More ...